Bookmark

Add to MyYahoo RSS

Pharmaceutical News

Pharmaceuticals news continually updated from thousands of sources around the net.

1 hr ago | Scoop

Tackling a decline of pharmaceutical success

Bart Ellenbroek A Victoria University of Wellington researcher will discuss why pharmaceutical industry success rates are so low and suggest solutions to tackle this crisis at an inaugural professorial lecture next Tuesday. Professor Bart Ellenbroek, from the School of Psychology, will focus on why the pharmaceutical industry is less successful, in terms of new drug registrations when there has been increasing expenditure on research and development over the last few decades.

Comment?

Related Topix: Pharmacology, Medicine

5 hrs ago | Star Tribune

Drug prices soar as Big Pharma targets discount program

Until May 1999, the daytime speed limit in Montana was "reasonable and prudent." Leadfoots from around the country called it the home of the Montanabahn.

Comment?

Related Topix: US Politics, US News, Gil Gutknecht, Republican, US House of Representatives, Medicine, Hypertension, Health, Hennepin County, MN, Opinion

6 hrs ago | Applied Clinical Trials

Functional Outsourcing in the Pharmaceutical Industry - a Project Management Perspective

It is estimated that by the end of 2014, pharmaceutical companies will lose approximately $78 billion USD as a result of medications going off patent.1 Additionally, the industry is facing significant competition and a widening gap between proposed pricing for new medications and what reimbursement structures are willing to pay. To address some of these trends and in an effort to "do more with less," the pharmaceutical industry has been outsourcing not only its IT and back-office functions, but also parts of its core business for some years, and which led to the emergence and growth of the large contract research organization .

Comment?

Related Topix: Outsourcing, Marketing

10 hrs ago | Business Journal

How cost pressures under Obamacare can be a boon to the biotech industry

President Barack Obama's signature Affordable Care Act has spurred plenty of attacks on the pharmaceutical industry, but it has also created opportunities, according to Flagship Ventures partner Harry Wilcox. The recent launches of drugs with high up-front costs have revived the longstanding debate over how much new medicines ought to cost.

Comment?

Related Topix: Biotech, US Politics, US News, Barack Obama, Venture Capital, Emerging Technology

13 hrs ago | GlobeNewswire

Deadline in Lawsuit for Investors in Impax Laboratories Inc (IPXL)...

The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of shares of Impax Laboratories Inc over alleged Violations of Federal Securities Laws by Impax Laboratories Inc. If you purchased shares of Impax Laboratories Inc , you have certain options and for certain investors are short and strict deadlines running. Deadline: October 13, 2014.

Comment?

Related Topix: Biotech, Impax Laboratories, Medicine, Healthcare Industry, Startups, Food and Drug Administration

14 hrs ago | Business Journal

Lannett defends pricing practices amid probe

Lannett Co. Inc. said Tuesday its outside review of the company's pricing practices for digoxin, a generic heart medicine, found the company acted in compliance with applicable laws and regulations.

Comment?

Related Topix: Lannett Company, Biotech, Medicine, Healthcare Industry, Digoxin (generic), Lanoxin, Digitek, Philadelphia, PA, Heart Failure, Health

16 hrs ago | Seeking Alpha

If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits

If Achillion's nucleotide , ACH-3422, works as well or worse than Gilead's Sovaldi, there is little use for it in the market. Since May, Achillion has experienced an avalanche of selling by insiders and major holders, and no reported buying by institutions.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Gilead Sciences, Hepatitis, Health, Merck , Achillion Pharmaceuticals

18 hrs ago | Pharmaceutical Online

Micromeritics To Participate In University Of Maryland Tableting Course

This October, the University of Maryland School of Pharmacy will hold its second annual Tablets & Capsules Hands-On Short Course. The training will provide a general overview of the production of multiparticulate beads, capsules, and tables.

Comment?

Mon Sep 15, 2014

Hispanic Business

McKesson Clear Coverage Appraised at CMMI Level 3

Today McKesson Health Solutions announced that the Clear Coverage TM platform has been reappraised at Level 3 of the CMMI Institute's Capability Maturity Model Integration , a process improvement training and appraisal program administered by , Senior Vice President, CIO/CTO at McKesson Health Solutions. 'Attaining CMMI Level 3 reaffirms the Clear Coverage team's dedication to defined development processes that help reduce risk, sustain high quality and support continuous process improvement for our customers.'

Comment?

Related Topix: Biotech, Medicine, McKesson, Household Products, Healthcare Industry, CIO News

PR-inside.com

New Report Available: Kukje Pharmaceutical Industry Co., Ltd....

This comprehensive SWOT profile of Kukje Pharmaceutical Industry Co., Ltd. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats.

Comment?

AmericanBankingNews.com

Raptor Pharmaceutical Corp. Trading Down 6.1% After Insider Selling

Raptor Pharmaceutical Corp. was down 6.1% during trading on Monday after an insider sold shares in the company, ARN reports. The stock traded as low as $10.26 and last traded at $10.46, with a volume of 230,583 shares.

Comment?

Related Topix: Raptor Pharmaceuticals

AmericanBankingNews.com

Achillion Pharmaceuticals Receives Average Rating of "Buy" from Brokerages

Achillion Pharmaceuticals has received a consensus recommendation of "Buy" from the twelve analysts that are presently covering the company, ARN reports . One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have assigned a buy rating to the company.

Comment?

Related Topix: Achillion Pharmaceuticals

AmericanBankingNews.com

McKesson Receives "BBB+" Credit Rating

McKesson has received a "BBB+" credit rating from analysts at Morningstar . The firm's "BBB+" rating indicates that the company is a moderate default risk.

Comment?

Related Topix: Biotech, Medicine, McKesson, Household Products, Healthcare Industry

Business Journal

Mylan gets deal for Hepatitis C medicines in developing countries

Mylan Inc. said it had licensed a Hepatitis C treatment for developing countries.

Comment?

Related Topix: Biotech, Medicine, Mylan Laboratories, Healthcare Industry, Hepatitis, Health, Dey, Startups

Business Journal

Mylan gets deal for Hepatitis C medicines in developing countries

Southpointe-based Mylan said Mylan Laboratories Ltd. said its deal with Gilead includes non-exclusive rights for sofosbuvir, also known as Sovaldi, and a single-tablet regimen of ledipasvir/sofosbuvir in 91 countries that have 54 percent of the infected population of Hepatitis C. Mylan said it would be able to manufacture low-cost versions of the medicines, which were approved by the FDA in 2013 and 2014. "Hepatitis C is a growing public health problem in developing countries, with Central and East Asia and North Africa among the regions most affected by this disease.

Comment?

Related Topix: Biotech, Medicine, Mylan Laboratories, Healthcare Industry, Dey, Startups, Hepatitis, Health

Benzinga

US Stock Futures Down Ahead Of Industrial Production Report

US stock futures traded lower in early pre-market trade, ahead of economic data. The Empire State manufacturing index for September will be released at 8:30 a.m. ET, while industrial production data for August will be released at 9:15 a.m. ET.

Comment?

Related Topix: Biotech, Medicine, Mylan Laboratories, Healthcare Industry, Dey, Startups, Manufacturing, Industrial Machines, Scientific Instruments, Danaher

Sat Sep 13, 2014

Seeking Alpha

Teva Pharmaceutical Is Poised To Grow

Teva is trying to recover the Copaxone sales loss due to patent expiration by introducing an improved version of Copaxone 40mg. Teva revealed positive data from the phase 3 study of its drug reslizumab for the treatment of moderate to severe asthma.

1 comment

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Asthma, Health, AstraZeneca, AstraZeneca Group, Healthcare Industry

AmericanBankingNews.com

Insider Selling: Raptor Pharmaceutical Corp. Director Sells 10,000 Shares of Stock

Raptor Pharmaceutical Corp. Director Raymond Anderson sold 10,000 shares of the stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $10.81, for a total transaction of $108,100.00.

Comment?

Related Topix: Raptor Pharmaceuticals

Seeking Alpha

FDA tentatively approves Mylan's HIV combo

The FDA grants tentative approval for Mylan's emtricitabine and tenofovir disoproxil fumarate combination tablets co-packaged with nevirapine tablets for the treatment of patients with HIV-1. The product is cleared for use alone or in combination with other antiretrovirals for the treatment of HIV-1 infection in adults and pediatric patients at least 12 years old and weighing at least 38 kg.

Comment?

Related Topix: HIV/AIDS, Health, Dey, Biotech, Startups, Medicine, Mylan Laboratories, Healthcare Industry, Viramune, Nevirapine (generic)

The China Post

Eastman Chemical to purchase Taminco in US$2.8 billion deal

Eastman Chemical Co. said Thursday it would pay US$1.7 billion in cash to take over Taminco Corp, the world's largest maker of alkylamines, crucial to the pharmaceutical industry and others.

Comment?

Related Topix: Rubber-Plastics, Chemicals, Eastman Chemical

•••
•••
•••
•••

Pharmaceuticals Jobs

•••
•••
•••
•••